Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.01 – $5.00
0% from low
Exchange
OTC Link
CS
SIGYN THERAPEUTICS INC
No one on the platform currently holds SIGY.
No tracked institution reports a position in SIGY as of their last filing.
| Execution date | Ratio |
|---|---|
| 2024-01-31 | 1-for-40reverse |
| 2004-10-19 | 3-for-1 |
No one on the platform has traded SIGY yet.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $2M | — | $-420.00 | $-420.00–$-420.00 | — | 1 |
| 2027 | $7M | +250.3% | $-300.00 | $-300.00–$-300.00 | — | 1 |
| 2028 | $15M | +121.3% | $60.00 | $60.00–$60.00 | 0.0× | 1 |
| 2029 | $26M | +71.2% | $540.00 | $540.00–$540.00 | 0.0× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| SIGYSigyn Therapeutics, Inc. | $0.03 | +0.00% | $48161 | — |
| ARUXFAcrux Limited | $0.00 | +0.00% | $1M | — |
| AXIMAXIM Biotechnologies, Inc. | $0.00 | -4.35% | $1M | — |
| CLABFCore One Labs Inc. | $0.00 | +0.00% | $471 | — |
| HAVLFHAVN Life Sciences Inc. | $0.00 | +0.00% | $2565 | — |
| IRMEIR-Med Inc. | $0.00 | +0.00% | $162202 | — |
Source: Financial Modeling Prep · peers by sector/industry
| LMLLFPharmadrug Inc. | $0.00 | +0.00% | $469749 | — |
$OGEN crushing $SIGY dilution and near certain failure of the nasal scam in the phase II clinical trials to look forward to here.
View on StockTwits ↗$OGEN Scam and fraud company with continual and ongoing pivots to decreasingly credible lead products. It looks like $SIGY is the new garbage bag pivot that will lead to inevitable dilution and issues with listing compliance.
View on StockTwits ↗@darkreef333 yeah such great news that everyone is dumping 😂😂 $SIGY
View on StockTwits ↗$OGEN 3 trading days since the “news” and $OGEN IS DOWN 21%, and $SIGY is down around 30%. Glad people aren’t falling for their bs scamming anymore
View on StockTwits ↗@darkreef333 why $SIGY? Is there potential here?
View on StockTwits ↗$SIGY $HIMS These two stocks are my biggest holdings
View on StockTwits ↗$SIGY .10 and just starting. $100K market cap. This could def see $1
View on StockTwits ↗https://nfne.ws/271325 $SIGY #ldmicro #Publishing #OTC #OTCMarkets #OTCStocks #Investing
View on StockTwits ↗$SIGY Best kept secret on Wall Street likely to explode in value soon. Very few shares of buying will spike price over $10.
View on StockTwits ↗https://nfne.ws/270888 $SIGY #ldmicro #Publishing #OTC #OTCMarkets #OTCStocks #Investing
View on StockTwits ↗$SIGY Brilliant piece that captures SIGY's situation perfectly. So if you want to update your understanding of SIGY or get to know SIGY better, this is essential reading. https://beyondspx.com/quote/SIGY/analysis/sigyn-therapeutics-addressing-global-health-crises-with-novel-blood-purification-sigy
View on StockTwits ↗$SIGY Sigyn vs. Statins: Better and Faster Sigyn Therapy™ dramatically outperforms statins: - Works in a single session versus weeks or months for statins. - Lowers both LDL-C and Lp(a), unlike statins. - Reduces inflammation and immediate MACE risk. - Safe and effective for statin-intolerant patients. $PFE $BMY $DVA
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.